lidocaine has been researched along with Pain, Chronic in 73 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Excerpt | Relevance | Reference |
---|---|---|
"To compare the incidence in postsurgical persistent pain following breast cancer surgery in women receiving intravenous lidocaine compared to saline using validated pain instruments in accordance with the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) recommendations." | 9.27 | The Effect of Intraoperative Systemic Lidocaine on Postoperative Persistent Pain Using Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials Criteria Assessment Following Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Cont ( Bialek, JM; De Oliveira, GS; Goodwin, E; Kendall, MC; McCarthy, RJ; Nader, A; Panaro, S, 2018) |
"We aimed to compare the effects of intraoperative lidocaine and magnesium on postoperative functional recovery and chronic pain after mastectomy due to breast cancer." | 9.24 | Effects of systemic lidocaine versus magnesium administration on postoperative functional recovery and chronic pain in patients undergoing breast cancer surgery: A prospective, randomized, double-blind, comparative clinical trial. ( Kim, MH; Kim, SI; Lee, KY; Park, HS; Park, S; Yoo, YC, 2017) |
"There are few data to support paraspinous lidocaine injection use in patients with nonspecific chronic low back pain." | 9.22 | Paraspinous Lidocaine Injection for Chronic Nonspecific Low Back Pain: A Randomized Controlled Clinical Trial. ( Alfieri, FM; Battistella, LR; da Rocha, ID; Filippo, TR; Fregni, F; Imamura, M; Imamura, ST; Morales-Quezada, L; Neto, RB; Onoda Tomikawa, LC; Onoda Tomikawa, LG; Targino, RA, 2016) |
"The 5% Lidocaine patch is used for treating chronic neuropathic pain conditions such as chronic back pain (CBP), diabetic neuropathy and complex regional pain syndrome, but is effective in a variable proportion of patients." | 9.16 | Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study. ( Apkarian, AV; Baliki, MN; Chanda, ML; Hashmi, JA; Huang, L; Parks, EL; Schnitzer, T, 2012) |
"Local anesthetics, such as the 5% transdermal lidocaine patch (5LP), have been frequently used in the treatment of musculoskeletal pain, especially chronic low back pain (CLBP)." | 9.05 | The Efficacy, Effectiveness and Safety of 5% Transdermal Lidocaine Patch for Chronic Low Back Pain: A Narrative Review. ( Felix, ER; Klass, S; Santana, JA, 2020) |
"Systemic administration of the local anaesthetic lidocaine is antinociceptive in both acute and chronic pain states, especially in acute postoperative and chronic neuropathic pain." | 9.01 | Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review. ( Brandenburger, T; Hermanns, H; Hollmann, MW; Lirk, P; Piegeler, T; Stevens, MF; Werdehausen, R, 2019) |
"Eighty-eight articles regarding iv lidocaine were included: 36 in vitro studies evaluating the effect on ion channels and receptors; 31 animal studies concerning acute and chronic pain and inflammatory models; 21 clinical studies concerning acute and chronic pain." | 8.93 | The in vitro mechanisms and in vivo efficacy of intravenous lidocaine on the neuroinflammatory response in acute and chronic pain. ( Radema, SA; Scheffer, GJ; Steegers, MA; van Berkum, BF; van den Heuvel, SA; van der Wal, SE; Vaneker, M; Vissers, KC, 2016) |
" With more and more perianesthesia nurses involved with chronic pain management, it is imperative they understand the special nursing care needs of patients receiving intravenous lidocaine infusion therapy." | 8.12 | Nursing Care During Lidocaine Infusion Therapy for Chronic Pain. ( Wren, KR, 2022) |
"To evaluate the safety of and long-term pain relief due to intravenous lidocaine infusion for the treatment of chronic pain in a tertiary pain management clinic." | 7.88 | Tertiary Care Clinical Experience with Intravenous Lidocaine Infusions for the Treatment of Chronic Pain. ( Bokat, CE; Brogan, S; Donaldson, GW; Hagn, EE; Hare, BD; Iacob, E; Junkins, SR; Kennington, KS; Okifuji, A; Sindt, J; Tadler, SC, 2018) |
"Chronic postsurgical pain (CPSP) and sensory disturbances at the surgical sites were evaluated 3 months after surgery." | 6.84 | The Effects of Intravenous Lidocaine Infusions on the Quality of Recovery and Chronic Pain After Robotic Thyroidectomy: A Randomized, Double-Blinded, Controlled Study. ( Choi, KW; Chung, WY; Joe, YE; Kang, SW; Lee, JH; Lee, JR; Nam, KH, 2017) |
"Chronic pain is currently considered a disease state with biopsychosocial consequences and a negative impact on patients' quality of life (QoL)." | 6.82 | Changing the paradigm in postherpetic neuralgia treatment: lidocaine 700 mg medicated plaster. ( Fornasari, D; Magni, A; Pais, P; Palao, T; Polati, E; Sansone, P, 2022) |
"Treatment of chronic pain conditions is commonly assessed at specific endpoints at preset times during or after treatment by analysis of the total study population." | 6.78 | A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia. ( Dahan, A; Krebs-Brown, A; Martini, CH; Olofsen, E; Passier, P; Stoker, M; Yassen, A, 2013) |
"Chronic pain was assessed 3 to 6 months after breast surgery in 51 patients of the lidocaine group and 46 patients of the control group." | 6.55 | Effect of Perioperative Intravenous Lidocaine Infusion on Acute and Chronic Pain after Breast Surgery: A Meta-Analysis of Randomized Controlled Trials. ( Chang, YC; Chen, MJ; Cheng, SP; Liu, CL; Liu, TP; Yang, PS, 2017) |
"We assigned 44 women diagnosed with chronic myofascial pelvic pain associated with trigger points to either the magnesium-based infiltrate (n = 15), lidocaine infiltrate (n = 17), or waitlist (n = 12) group." | 5.51 | Magnesium-Based Trigger Point Infiltrations Versus Local Anaesthetic Infiltrations in Chronic Pelvic Myofascial Pain: A Randomized, Double-Blind, Controlled Study. ( Chamberlain, S; Henry, R; Leitch, J; Nitsch, R; Pudwell, J; Webb, A, 2022) |
"To compare the incidence in postsurgical persistent pain following breast cancer surgery in women receiving intravenous lidocaine compared to saline using validated pain instruments in accordance with the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) recommendations." | 5.27 | The Effect of Intraoperative Systemic Lidocaine on Postoperative Persistent Pain Using Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials Criteria Assessment Following Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Cont ( Bialek, JM; De Oliveira, GS; Goodwin, E; Kendall, MC; McCarthy, RJ; Nader, A; Panaro, S, 2018) |
"We aimed to compare the effects of intraoperative lidocaine and magnesium on postoperative functional recovery and chronic pain after mastectomy due to breast cancer." | 5.24 | Effects of systemic lidocaine versus magnesium administration on postoperative functional recovery and chronic pain in patients undergoing breast cancer surgery: A prospective, randomized, double-blind, comparative clinical trial. ( Kim, MH; Kim, SI; Lee, KY; Park, HS; Park, S; Yoo, YC, 2017) |
"Laser irradiation caused an immediate decrease in low back pain post-procedure similar to pain reduction caused by lidocaine injection." | 5.22 | Photobiomodulation of the dorsal root ganglion for the treatment of low back pain: A pilot study. ( Anders, JJ; Chavantes, MC; de Holanda, CV; de Oliveira, JO; Holanda, VM; Silva, DF; Wu, X, 2016) |
"This qualitative review found insufficient, heterogenous evidence and therefore no recommendation can be made for lidocaine infusion treatment in patients with chronic neuropathic pain due to spinal cord injury, peripheral nerve injury, diabetic neuropathy, postherpetic neuralgia, or complex regional pain syndrome type II." | 5.22 | Intravenous Lidocaine in Chronic Neuropathic Pain: A Systematic Review. ( Argoff, CE; Bhullar, RK; Koutalianos, EP; Lee, JH; Leimer, EM, 2022) |
"There are few data to support paraspinous lidocaine injection use in patients with nonspecific chronic low back pain." | 5.22 | Paraspinous Lidocaine Injection for Chronic Nonspecific Low Back Pain: A Randomized Controlled Clinical Trial. ( Alfieri, FM; Battistella, LR; da Rocha, ID; Filippo, TR; Fregni, F; Imamura, M; Imamura, ST; Morales-Quezada, L; Neto, RB; Onoda Tomikawa, LC; Onoda Tomikawa, LG; Targino, RA, 2016) |
"Lidocaine injection seems to be better for reducing the severity of chronic pelvic pain secondary to abdominal wall trigger points compared to ischemic compression via physical therapy." | 5.20 | Anaesthetic injection versus ischemic compression for the pain relief of abdominal wall trigger points in women with chronic pelvic pain. ( Braz, CA; Candido-dos-Reis, FJ; Montenegro, ML; Nogueira, AA; Poli-Neto, OB; Rosa-e-Silva, JC, 2015) |
"The 5% Lidocaine patch is used for treating chronic neuropathic pain conditions such as chronic back pain (CBP), diabetic neuropathy and complex regional pain syndrome, but is effective in a variable proportion of patients." | 5.16 | Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study. ( Apkarian, AV; Baliki, MN; Chanda, ML; Hashmi, JA; Huang, L; Parks, EL; Schnitzer, T, 2012) |
"Local anesthetics, such as the 5% transdermal lidocaine patch (5LP), have been frequently used in the treatment of musculoskeletal pain, especially chronic low back pain (CLBP)." | 5.05 | The Efficacy, Effectiveness and Safety of 5% Transdermal Lidocaine Patch for Chronic Low Back Pain: A Narrative Review. ( Felix, ER; Klass, S; Santana, JA, 2020) |
"Systemic administration of the local anaesthetic lidocaine is antinociceptive in both acute and chronic pain states, especially in acute postoperative and chronic neuropathic pain." | 5.01 | Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review. ( Brandenburger, T; Hermanns, H; Hollmann, MW; Lirk, P; Piegeler, T; Stevens, MF; Werdehausen, R, 2019) |
"We evaluate the safety and efficacy of intravenous lidocaine in adult patients with acute and chronic pain who are undergoing pain management in the emergency department (ED)." | 4.98 | Safety and Efficacy of Intravenous Lidocaine for Pain Management in the Emergency Department: A Systematic Review. ( Bellolio, MF; Cabrera, D; E Silva, LOJ; Erwin, PJ; Motov, S; Murad, MH; Scherber, K; West, CP, 2018) |
"Eighty-eight articles regarding iv lidocaine were included: 36 in vitro studies evaluating the effect on ion channels and receptors; 31 animal studies concerning acute and chronic pain and inflammatory models; 21 clinical studies concerning acute and chronic pain." | 4.93 | The in vitro mechanisms and in vivo efficacy of intravenous lidocaine on the neuroinflammatory response in acute and chronic pain. ( Radema, SA; Scheffer, GJ; Steegers, MA; van Berkum, BF; van den Heuvel, SA; van der Wal, SE; Vaneker, M; Vissers, KC, 2016) |
" In patients with neuropathic pain, topical forms of both capsaicin and lidocaine have been shown to be useful in the treatment of postherpetic neuralgia and diabetic peripheral neuropathic pain." | 4.89 | Topical therapies in the management of chronic pain. ( Galluzzi, KE; Stanos, SP, 2013) |
"What is this study about? This study examined data of patients with chronic pain who received an infusion at our hospital with two drugs, lidocaine and ketamine, in an effort to reduce pain." | 4.31 | Simultaneous application of lidocaine and ketamine during ambulatory infusion therapy: a retrospective analysis. ( Ruppen, W; Schneider, T; Striebel, J, 2023) |
" LCipsi inactivation with lidocaine increased cold allodynia 2 days after nerve injury but not later." | 4.12 | Nerve injury induces transient locus coeruleus activation over time: role of the locus coeruleus-dorsal reticular nucleus pathway. ( Berrocoso, E; Bravo, L; Camarena-Delgado, C; Garcia-Partida, JA; Llorca-Torralba, M; López-Martín, C; Mico, JA; Suárez-Pereira, I, 2022) |
" With more and more perianesthesia nurses involved with chronic pain management, it is imperative they understand the special nursing care needs of patients receiving intravenous lidocaine infusion therapy." | 4.12 | Nursing Care During Lidocaine Infusion Therapy for Chronic Pain. ( Wren, KR, 2022) |
"We conclude that CSF lavage could be a helpful maneuver to clear lidocaine and betamethasone and avoid potential nerve damage caused by an unintentional intrathecal injection during an epidural injection for the treatment of chronic low back pain." | 3.91 | An inadvertent subarachnoid injection reversed by cerebrospinal fluid lavage for the treatment of chronic low back pain: A case report. ( Liu, C; Liu, S; Pan, Y; Sun, J; Sun, X; Xu, J, 2019) |
"To evaluate the safety of and long-term pain relief due to intravenous lidocaine infusion for the treatment of chronic pain in a tertiary pain management clinic." | 3.88 | Tertiary Care Clinical Experience with Intravenous Lidocaine Infusions for the Treatment of Chronic Pain. ( Bokat, CE; Brogan, S; Donaldson, GW; Hagn, EE; Hare, BD; Iacob, E; Junkins, SR; Kennington, KS; Okifuji, A; Sindt, J; Tadler, SC, 2018) |
" Stratification by diagnosis showed a treatment effect of lidocaine plaster for all underlying conditions with highest treatment effects for diabetic polyneuropathy and postherpetic neuralgia." | 3.78 | Patient perceptions associated with the 5% lidocaine medicated plaster in daily practice. ( Müller-Schwefe, GH; Überall, MA, 2012) |
" The cumulative dosage of sufentanil in perioperative period was significantly lower (149." | 3.11 | Effect of lidocaine perioperative infusion on chronic postsurgical pain in patients undergoing thoracoscopic radical pneumonectomy. ( Ding, H; Lian, C; Lu, Y; Shangguan, W; Shao, C; Shi, J; Wang, N; Wu, J, 2022) |
"Chronic postsurgical pain (CPSP) and sensory disturbances at the surgical sites were evaluated 3 months after surgery." | 2.84 | The Effects of Intravenous Lidocaine Infusions on the Quality of Recovery and Chronic Pain After Robotic Thyroidectomy: A Randomized, Double-Blinded, Controlled Study. ( Choi, KW; Chung, WY; Joe, YE; Kang, SW; Lee, JH; Lee, JR; Nam, KH, 2017) |
"Chronic pain is currently considered a disease state with biopsychosocial consequences and a negative impact on patients' quality of life (QoL)." | 2.82 | Changing the paradigm in postherpetic neuralgia treatment: lidocaine 700 mg medicated plaster. ( Fornasari, D; Magni, A; Pais, P; Palao, T; Polati, E; Sansone, P, 2022) |
"Provoked vestibulodynia (PVD), a frequent form of chronic genital pain, is associated with decreased sexual function for afflicted women, as well as impoverished sexual satisfaction for women and their partners." | 2.79 | A comparison of cognitive-behavioral couple therapy and lidocaine in the treatment of provoked vestibulodynia: study protocol for a randomized clinical trial. ( Aerts, L; Bergeron, S; Corsini-Munt, S; Delisle, I; Mayrand, MH; McDuff, P; Rosen, NO; Santerre-Baillargeon, M; Steben, M, 2014) |
"Treatment of chronic pain conditions is commonly assessed at specific endpoints at preset times during or after treatment by analysis of the total study population." | 2.78 | A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia. ( Dahan, A; Krebs-Brown, A; Martini, CH; Olofsen, E; Passier, P; Stoker, M; Yassen, A, 2013) |
"Lidocaine is an amino amide with a well-established role as a local anesthetic agent." | 2.72 | Lidocaine Infusions for Pain Management in Pediatrics. ( Anghelescu, DL; Davis, MS; Hall, EA; Sauer, HE, 2021) |
"Chronic postsurgical pain (CPSP) is an important and well recognized cause of much long-term suffering, which in some cases may be preventable and affects many people living with cancer." | 2.58 | Chronic postsurgical pain and cancer: the catch of surviving the unsurvivable. ( Bhaskar, A; Humble, SR; Jayaweera, A; Varela, N, 2018) |
"Chronic pain was assessed 3 to 6 months after breast surgery in 51 patients of the lidocaine group and 46 patients of the control group." | 2.55 | Effect of Perioperative Intravenous Lidocaine Infusion on Acute and Chronic Pain after Breast Surgery: A Meta-Analysis of Randomized Controlled Trials. ( Chang, YC; Chen, MJ; Cheng, SP; Liu, CL; Liu, TP; Yang, PS, 2017) |
"Management of persistent idiopathic facial pain (PIFP) can be challenging." | 1.91 | Effect of neuropathic pain on sphenopalatine ganglion block responses in persistent idiopathic facial pain. ( Akçaboy, EY; Çelik, Ş; Göksu, H; Kaya, SS; Şahin, Ş; Yıldız, G, 2023) |
"It has played a role in chronic pain management in recent decades, and continues to be a useful tool for pain specialists." | 1.72 | Use of intravenous lignocaine in the perioperative and chronic pain setting. ( Crabtree, S, 2022) |
"The chronic cervical facet joint pain was diagnosed with cervical facet joint nerve blocks at a prevalence of 49." | 1.56 | Assessment of Prevalence of Cervical Facet Joint Pain with Diagnostic Cervical Medial Branch Blocks: Analysis Based on Chronic Pain Model. ( Cash, KA; Hirsch, JA; Kaye, AD; Kosanovic, R; Manchikanti, L; Pampati, V; Soin, A, 2020) |
"In patients with focal nerve injury and neuropathic pain cutting the nerve to obtain permanent pain reduction can be considered." | 1.48 | Predictive value of a diagnostic block in focal nerve injury with neuropathic pain when surgery is considered. ( Dahan, A; de Boer, R; Eekhof, JLA; Kliot, M; Malessy, MJA; Muñoz Romero, I; Pondaag, W; van Zwet, EW, 2018) |
"Patients with neuropathic pain are highly motivated for pain relief, and as motivational factors such as expectations of reward, as well as pain processing in itself, are related to the dopaminergic system, it can be speculated that dopamine release contributes to placebo effects in neuropathic pain." | 1.48 | Dopaminergic tone does not influence pain levels during placebo interventions in patients with chronic neuropathic pain. ( Baastrup, C; Benedetti, F; Grosen, K; Hall, KT; Jensen, TS; Kaptchuk, TJ; Moslemi, K; Petersen, GL; Price, DD; Skyt, I; Svensson, P; Vase, L, 2018) |
"In contrast, CRF i." | 1.48 | Corticotropin-Releasing Factor in the Brain and Blocking Spinal Descending Signals Induce Hyperalgesia in the Latent Sensitization Model of Chronic Pain. ( Chen, W; Marvizón, JC; Taché, Y, 2018) |
"Myocardial infarction is the leading cause of death worldwide." | 1.46 | Cardioprotection induced in a mouse model of neuropathic pain via anterior nucleus of paraventricular thalamus. ( Chang, YT; Chen, CC; Chen, WH; Chen, YH; Cheng, YF; Shih, HC; Shyu, BC, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.37) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 54 (73.97) | 24.3611 |
2020's | 18 (24.66) | 2.80 |
Authors | Studies |
---|---|
Voute, M | 1 |
Morel, V | 1 |
Pickering, G | 1 |
Wren, KR | 1 |
Camarena-Delgado, C | 1 |
Llorca-Torralba, M | 1 |
Suárez-Pereira, I | 1 |
Bravo, L | 1 |
López-Martín, C | 1 |
Garcia-Partida, JA | 1 |
Mico, JA | 1 |
Berrocoso, E | 1 |
Crabtree, S | 1 |
Leitch, J | 1 |
Webb, A | 1 |
Pudwell, J | 1 |
Chamberlain, S | 1 |
Henry, R | 1 |
Nitsch, R | 1 |
Fornasari, D | 1 |
Magni, A | 1 |
Pais, P | 1 |
Palao, T | 1 |
Polati, E | 1 |
Sansone, P | 1 |
Lu, Y | 1 |
Ding, H | 1 |
Shao, C | 1 |
Wang, N | 1 |
Shi, J | 1 |
Lian, C | 1 |
Wu, J | 1 |
Shangguan, W | 1 |
Lee, JH | 2 |
Koutalianos, EP | 1 |
Leimer, EM | 1 |
Bhullar, RK | 1 |
Argoff, CE | 1 |
Kaya, SS | 3 |
Çelik, Ş | 3 |
Akçaboy, EY | 3 |
Göksu, H | 3 |
Yıldız, G | 3 |
Şahin, Ş | 3 |
Jin, L | 1 |
Liang, Y | 1 |
Yu, Y | 1 |
Miao, P | 1 |
Huang, Y | 1 |
Xu, L | 1 |
Wang, H | 1 |
Wang, C | 1 |
Huang, J | 1 |
Guo, K | 1 |
Striebel, J | 1 |
Ruppen, W | 1 |
Schneider, T | 1 |
Hui, J | 1 |
Seko, K | 1 |
Shrikhande, G | 1 |
Ahmed, T | 1 |
Hill, C | 1 |
Reutter, C | 1 |
Shrikhande, A | 1 |
Santana, JA | 1 |
Klass, S | 1 |
Felix, ER | 1 |
Manchikanti, L | 3 |
Kosanovic, R | 1 |
Cash, KA | 3 |
Pampati, V | 3 |
Soin, A | 1 |
Kaye, AD | 1 |
Hirsch, JA | 1 |
Maloney, J | 1 |
Pew, S | 1 |
Wie, C | 1 |
Gupta, R | 1 |
Freeman, J | 1 |
Strand, N | 1 |
Li, T | 1 |
Feng, XY | 1 |
Feng, XM | 1 |
Lv, JW | 1 |
Lv, TT | 1 |
Wang, SY | 1 |
Hall, EA | 1 |
Sauer, HE | 1 |
Davis, MS | 1 |
Anghelescu, DL | 1 |
Boelens, OB | 1 |
Maatman, RC | 1 |
Scheltinga, MR | 2 |
van Laarhoven, K | 1 |
Roumen, RM | 2 |
Kendall, MC | 2 |
McCarthy, RJ | 1 |
Panaro, S | 1 |
Goodwin, E | 1 |
Bialek, JM | 1 |
Nader, A | 1 |
De Oliveira, GS | 1 |
Herndon, CL | 1 |
Horodyski, M | 1 |
Vincent, HK | 1 |
Iacob, E | 1 |
Hagn, EE | 1 |
Sindt, J | 1 |
Brogan, S | 1 |
Tadler, SC | 1 |
Kennington, KS | 1 |
Hare, BD | 1 |
Bokat, CE | 1 |
Donaldson, GW | 1 |
Okifuji, A | 1 |
Junkins, SR | 1 |
Cheng, YF | 1 |
Chang, YT | 1 |
Chen, WH | 1 |
Shih, HC | 1 |
Chen, YH | 1 |
Shyu, BC | 1 |
Chen, CC | 1 |
Skyt, I | 1 |
Moslemi, K | 1 |
Baastrup, C | 1 |
Grosen, K | 1 |
Benedetti, F | 1 |
Petersen, GL | 1 |
Price, DD | 1 |
Hall, KT | 1 |
Kaptchuk, TJ | 1 |
Svensson, P | 1 |
Jensen, TS | 1 |
Vase, L | 1 |
Kopach, O | 1 |
Zheng, K | 1 |
Dong, L | 1 |
Sapelkin, A | 1 |
Voitenko, N | 1 |
Sukhorukov, GB | 1 |
Rusakov, DA | 1 |
E Silva, LOJ | 1 |
Scherber, K | 1 |
Cabrera, D | 1 |
Motov, S | 1 |
Erwin, PJ | 1 |
West, CP | 1 |
Murad, MH | 1 |
Bellolio, MF | 1 |
Poli-Neto, OB | 2 |
Campos Martins Chamochumbi, C | 1 |
Toscano, P | 1 |
Pitanguy Julio, M | 1 |
Marques, W | 1 |
Rosa-E-Silva, JC | 2 |
Candido-Dos-Reis, FJ | 2 |
Nogueira, AA | 2 |
Soto, G | 1 |
Naranjo González, M | 1 |
Calero, F | 1 |
Humble, SR | 1 |
Varela, N | 1 |
Jayaweera, A | 1 |
Bhaskar, A | 1 |
Lam, K | 1 |
Vasey, C | 1 |
Ji, NN | 1 |
Kang, J | 1 |
Hua, R | 1 |
Zhang, YM | 1 |
Bicket, MC | 1 |
Cohen, SP | 1 |
Chen, W | 1 |
Taché, Y | 1 |
Marvizón, JC | 1 |
Kaluza, L | 1 |
Meents, JE | 1 |
Hampl, M | 1 |
Rösseler, C | 1 |
Hautvast, PAI | 1 |
Detro-Dassen, S | 1 |
Hausmann, R | 1 |
Schmalzing, G | 1 |
Lampert, A | 1 |
Malessy, MJA | 1 |
de Boer, R | 1 |
Muñoz Romero, I | 1 |
Eekhof, JLA | 1 |
van Zwet, EW | 1 |
Kliot, M | 1 |
Dahan, A | 2 |
Pondaag, W | 1 |
Nissen, MJ | 1 |
Brulhart, L | 1 |
Faundez, A | 1 |
Finckh, A | 1 |
Courvoisier, DS | 1 |
Genevay, S | 1 |
Sun, X | 1 |
Liu, S | 1 |
Liu, C | 1 |
Xu, J | 1 |
Sun, J | 1 |
Pan, Y | 1 |
Bailey, M | 1 |
Conger, A | 1 |
McCormick, ZL | 1 |
Henrie, AM | 1 |
Huang, R | 1 |
Jiang, L | 1 |
Cao, Y | 1 |
Liu, H | 1 |
Ping, M | 1 |
Li, W | 1 |
Xu, Y | 1 |
Ning, J | 1 |
Chen, Y | 1 |
Wang, X | 1 |
Moulin, DE | 1 |
Morley-Forster, PK | 1 |
Pirani, Z | 1 |
Rohfritsch, C | 1 |
Stitt, L | 1 |
Lee, JJ | 1 |
Nguyen, ET | 1 |
Harrison, JR | 1 |
Gribbin, CK | 1 |
Hurwitz, NR | 1 |
Cheng, J | 1 |
Boachie-Adjei, K | 1 |
Bogner, EA | 1 |
Moley, PJ | 1 |
Wyss, JF | 1 |
Lutz, GE | 1 |
Hermanns, H | 1 |
Hollmann, MW | 1 |
Stevens, MF | 1 |
Lirk, P | 1 |
Brandenburger, T | 1 |
Piegeler, T | 1 |
Werdehausen, R | 1 |
Sinha, P | 1 |
Sarkar, B | 1 |
Goswami, S | 1 |
Ray Karmakar, P | 1 |
Dasgupta, SR | 1 |
Basu, S | 1 |
Martini, CH | 1 |
Yassen, A | 1 |
Krebs-Brown, A | 1 |
Passier, P | 1 |
Stoker, M | 1 |
Olofsen, E | 1 |
Kim, SH | 1 |
Kim, DH | 1 |
Yoon, DM | 1 |
Yoon, KB | 1 |
Mooney, JJ | 1 |
Pagel, PS | 1 |
Kundu, A | 1 |
Stanos, SP | 1 |
Galluzzi, KE | 1 |
Effendy, I | 1 |
Gelber, A | 1 |
Lehmann, P | 1 |
Huledal, G | 1 |
Lillieborg, S | 1 |
Corsini-Munt, S | 1 |
Bergeron, S | 1 |
Rosen, NO | 1 |
Steben, M | 1 |
Mayrand, MH | 1 |
Delisle, I | 1 |
McDuff, P | 1 |
Aerts, L | 1 |
Santerre-Baillargeon, M | 1 |
Siawash, M | 1 |
de Jager-Kievit, JW | 1 |
Ten, WT | 1 |
Peirs, C | 1 |
Seal, RP | 1 |
Geurts, JW | 1 |
Kallewaard, JW | 1 |
Kessels, A | 1 |
Willems, PC | 1 |
van Santbrink, H | 1 |
Dirksen, C | 1 |
van Kleef, M | 1 |
Montenegro, ML | 1 |
Braz, CA | 1 |
van der Wal, SE | 1 |
van den Heuvel, SA | 1 |
Radema, SA | 1 |
van Berkum, BF | 1 |
Vaneker, M | 1 |
Steegers, MA | 1 |
Scheffer, GJ | 1 |
Vissers, KC | 1 |
Imamura, M | 1 |
Imamura, ST | 1 |
Targino, RA | 1 |
Morales-Quezada, L | 1 |
Onoda Tomikawa, LC | 1 |
Onoda Tomikawa, LG | 1 |
Alfieri, FM | 1 |
Filippo, TR | 1 |
da Rocha, ID | 1 |
Neto, RB | 1 |
Fregni, F | 1 |
Battistella, LR | 1 |
Chang, YC | 1 |
Liu, CL | 1 |
Liu, TP | 1 |
Yang, PS | 1 |
Chen, MJ | 1 |
Cheng, SP | 1 |
Takimoto, K | 1 |
Nishijima, K | 1 |
Ono, M | 1 |
Holanda, VM | 1 |
Chavantes, MC | 1 |
Silva, DF | 1 |
de Holanda, CV | 1 |
de Oliveira, JO | 1 |
Wu, X | 1 |
Anders, JJ | 1 |
Eker, HE | 1 |
Cok, OY | 1 |
Aribogan, A | 1 |
Arslan, G | 1 |
Choi, KW | 1 |
Nam, KH | 1 |
Lee, JR | 1 |
Chung, WY | 1 |
Kang, SW | 1 |
Joe, YE | 1 |
Ferrara, PE | 1 |
Ronconi, G | 1 |
Viscito, R | 1 |
Pascuzzo, R | 1 |
Rosulescu, E | 1 |
Ljoka, C | 1 |
Maggi, L | 1 |
Ferriero, G | 1 |
Foti, C | 1 |
Kim, MH | 1 |
Lee, KY | 1 |
Park, S | 1 |
Kim, SI | 1 |
Park, HS | 1 |
Yoo, YC | 1 |
Furuta, A | 1 |
Suzuki, Y | 1 |
Honda, M | 1 |
Koike, Y | 1 |
Naruoka, T | 1 |
Asano, K | 1 |
Chancellor, M | 1 |
Egawa, S | 1 |
Yoshimura, N | 1 |
Abbasi, A | 1 |
Roque-Dang, CM | 1 |
Malhotra, G | 1 |
Überall, MA | 1 |
Müller-Schwefe, GH | 1 |
Hashmi, JA | 1 |
Baliki, MN | 1 |
Huang, L | 1 |
Parks, EL | 1 |
Chanda, ML | 1 |
Schnitzer, T | 1 |
Apkarian, AV | 1 |
Gofeld, M | 1 |
Restrepo-Garces, CE | 1 |
Theodore, BR | 1 |
Faclier, G | 1 |
Wargo, BW | 1 |
Malla, Y | 1 |
López Ramírez, E | 1 |
Singh, V | 1 |
Falco, FJ | 1 |
Brenneis, C | 1 |
Kistner, K | 1 |
Puopolo, M | 1 |
Segal, D | 1 |
Roberson, D | 1 |
Sisignano, M | 1 |
Labocha, S | 1 |
Ferreirós, N | 1 |
Strominger, A | 1 |
Cobos, EJ | 1 |
Ghasemlou, N | 1 |
Geisslinger, G | 1 |
Reeh, PW | 1 |
Bean, BP | 1 |
Woolf, CJ | 1 |
RIDING, JE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Randomized Control Trial of Magnesium-Based Trigger Point Injections vs. Lidocaine-Only Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain[NCT02728037] | Phase 3 | 38 participants (Actual) | Interventional | 2016-04-30 | Terminated (stopped due to Low Enrollment, Adoption of investigational treatment into standard practice at our center.) | ||
Clinical Effect Observation for Electrical Pudendal Nerve Stimulation in Treating Urethral Pain Syndrome[NCT03671993] | 50 participants (Actual) | Interventional | 2018-10-05 | Completed | |||
Lidocaine Infusion for Postthoracotomy Pain Syndrome, A Prospective, Randomized, Double-blind, Placebo-controlled Trial (LIPPS Trial)[NCT03666299] | 72 participants (Anticipated) | Interventional | 2018-11-06 | Recruiting | |||
Randomized Trial Evaluating Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis - RELIEF-SCC[NCT04614610] | Phase 2 | 100 participants (Anticipated) | Interventional | 2024-01-01 | Not yet recruiting | ||
The Effect of Intraoperative Lidocaine Infusion and Intraoperative Lidocaine Combined With Ketamine Infusion on Opioid Consumption After Laparoscopic Bariatric Surgery: A Randomized Controlled Trial[NCT04524130] | Phase 4 | 87 participants (Anticipated) | Interventional | 2021-04-01 | Active, not recruiting | ||
Radiofrequency Ablation and Steroid Versus Steroid Alone for Relief of Pain in Patients With Advanced Knee and Hip Osteoarthritis[NCT05490355] | 80 participants (Anticipated) | Interventional | 2022-12-20 | Recruiting | |||
The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin[NCT01669967] | 34 participants (Actual) | Interventional | 2011-09-30 | Completed | |||
Intravenous Lidocaine and Time to Regression of the Sensory Block After Spinal Anesthesia With Isobaric Bupivacaine in Patients Undergoing Surgery to Treat Skin and Soft Tissue Tumors of the Lower Limbs[NCT04741880] | Phase 2/Phase 3 | 66 participants (Anticipated) | Interventional | 2021-06-17 | Recruiting | ||
Trial Evaluating multimOdal toPical Cream In CompArison to pLacebo (TOPICAL)[NCT03199417] | Phase 2/Phase 3 | 50 participants (Actual) | Interventional | 2017-05-01 | Terminated (stopped due to Terminated prematurely due to feasibility issues with rate of recruitment) | ||
A Comparison of Cognitive-behavioral Couple Therapy and Lidocaine in the Treatment of Provoked Vestibulodynia: A Randomized Clinical Trial[NCT01935063] | 108 participants (Actual) | Interventional | 2014-03-06 | Completed | |||
Local Injection of Lidocaine Versus Ischemic Compression in Treatment of Woman With Chronic Pelvic Pain Caused by Abdominal Myofascial Pain Syndrome: Randomized Clinical Trial.[NCT00628355] | Phase 4 | 30 participants (Actual) | Interventional | 2008-02-29 | Terminated (stopped due to Lidocaine injection group showed significant improvement in pain) | ||
Do Cervical Interlaminar Epidural Steroid Injections With Low-dose Lidocaine Cause Transient Objective Upper Extremity Weakness? A Prospective Randomized[NCT03382925] | Phase 4 | 16 participants (Actual) | Interventional | 2017-12-20 | Terminated (stopped due to Not enough cervical interlaminar patients who meet criteria in order to meet recruitment goals.) | ||
Study on the Effects of Paraspinal Lidocaine Injection on Nonspecific Low Back Pain[NCT02387567] | Phase 3 | 378 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
Corticosteriods vs. Saline vs. Air Placebo Intra-articular Injections for Knee Osteoarthritis: A Single Blinded Prospective Randomized Trial[NCT02995083] | Early Phase 1 | 0 participants (Actual) | Interventional | 2017-06-30 | Withdrawn (stopped due to Study deemed not feasible) | ||
Minimally Invasive Knee Osteoarthritis Pain Control Via Adductor Canal Block Versus Intra-articular Steroid and Lignocaine Injection : a Single-blinded Controlled Trial[NCT04264481] | 64 participants (Actual) | Interventional | 2019-07-12 | Completed | |||
[NCT01907997] | 90 participants (Actual) | Interventional | 2013-07-31 | Completed | |||
Mind-body Treatments for Chronic Back Pain[NCT03294148] | 151 participants (Actual) | Interventional | 2017-08-07 | Completed | |||
Randomized, Placebo-controlled Crossover Trial Evaluating Topical Lidocaine Patch(es) for Mechanical Neck Pain.[NCT04378959] | 76 participants (Actual) | Interventional | 2021-02-01 | Completed | |||
Pulsed Radiofrequency of Suprascapular Nerve and Shoulder Joint for Chronic Shoulder Pain: A Randomized Blind Active -Controlled Study[NCT04737993] | 150 participants (Anticipated) | Interventional | 2020-12-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
We analyzed the clinical response rate considering significative reduction of 50% of visual analogue scale or significative subjective improvement. (NCT00628355)
Timeframe: immediately, 1, 3 months after treatment
Intervention | percentage of participants (Number) | ||
---|---|---|---|
immediately after treatment | 1 month after treatment | 3 months after treatment | |
Anesthesia Injection | 45.3 | 60.2 | 69.9 |
TENS Plus Ischemic Compression | 17.5 | 8.8 | 7.0 |
"The pain will measured by using the visual analogue scale, that is represented by a straight line of 100mm starting at absence of pain and ending at point worst pain experienced or imagined." (NCT00628355)
Timeframe: immediately, 1, 3 months after treatment
Intervention | millimeters (Mean) | ||
---|---|---|---|
immediately after treatment | 1 month after treatment | 3 months after treatment | |
Anesthesia Injection | 33.7 | 27.1 | 20.8 |
Ischemic Compression | 52.7 | 53.0 | 50.8 |
1-week average pain intensity, 0 - 10 numerical rating scale, where a higher score indicates more pain. (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | units on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 1.18 |
Placebo | 2.84 |
Usual Care | 3.13 |
Questionnaire to rate negative affect, scores range from 5 - 25, with a higher score meaning a stronger negative affect (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | score on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 8.30 |
Placebo | 7.70 |
Usual Care | 8.19 |
Back pain disability questionnaire measured on a scale of 0-100. A higher score indicates a higher severity of disability. (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | score on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 10.14 |
Placebo | 19.00 |
Usual Care | 20.68 |
Questionnaire used to help quantify an individual's pain experience. Measured 0-52. A higher score means a higher level of catastrophizing. (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | score on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 8.30 |
Placebo | 7.70 |
Usual Care | 8.19 |
Post-treatment-only outcome measure depicting a patient's subjective rating of overall improvement. Score ranges from 1-7 with a higher score indicating a higher level of change and improvement (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | score on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 6.14 |
Placebo | 3.61 |
Usual Care | 2.06 |
Questionnaire to rate positive affect, scores range from 5 - 25, a higher score means stronger affect (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | score on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 17.89 |
Placebo | 15.20 |
Usual Care | 14.98 |
Questionnaire measuring anger (5 items) with a score range of 5-25. Higher scores indicate a higher severity of anger. (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | score on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 9.52 |
Placebo | 9.89 |
Usual Care | 10.45 |
Questionnaire measuring anxiety (8 items). Scores range from 8-40 with a higher score meaning more severe levels of fear, anxious misery, hyperarousal, and somatic symptoms related to arousal. (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | score on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 15.02 |
Placebo | 13.89 |
Usual Care | 14.11 |
Questionnaire measuring sleep disturbance (8 items). Scores range from 8-40. Higher scores indicate higher levels of sleep disturbance (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | score on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 17.73 |
Placebo | 20.50 |
Usual Care | 20.89 |
Questionnaire measuring depression (8 items). Scores range from 8-32. A higher score indicates higher levels of depressive symptoms (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | score on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 12.23 |
Placebo | 11.75 |
Usual Care | 11.81 |
Questionnaire used to assess the subjective rating of kinesiophobia or fear of movement. Scores range from 11-44 with higher scores indicating greater fear of pain, movement, and injury. (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | score on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 16.41 |
Placebo | 22.16 |
Usual Care | 22.51 |
Questionnaire used to assess daily drinking (number of drinks consumed over past two weeks) (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | Drinks (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 11.63 |
Placebo | 12.88 |
Usual Care | 8.02 |
Questionnaire used to assess daily cannabis use (number of grams consumed over past two weeks) (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | Grams of cannabis (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 6.76 |
Placebo | 3.31 |
Usual Care | 1.49 |
Questionnaire used to assess daily opioid use (number of pills consumed over past two weeks) (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | Opioid pills (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 1.29 |
Placebo | 0.36 |
Usual Care | 1.77 |
Post-treatment-only outcome measure depicting the patient's satisfaction with the treatment. Measured 0 - 100. A higher score means higher satisfaction with treatment/ (NCT03294148)
Timeframe: At post-treatment fMRI session, approximately 1 month after randomization
Intervention | score on a scale (Mean) |
---|---|
Pain Reprocessing Therapy (PRT) | 92.40 |
Placebo | 57.61 |
Usual Care | 36.86 |
15 reviews available for lidocaine and Pain, Chronic
Article | Year |
---|---|
Topical Lidocaine for Chronic Pain Treatment.
Topics: Administration, Topical; Analgesics; Anesthetics, Local; Chronic Pain; Drug Therapy, Combination; Hu | 2021 |
Changing the paradigm in postherpetic neuralgia treatment: lidocaine 700 mg medicated plaster.
Topics: Anesthetics, Local; Chronic Pain; Humans; Lidocaine; Neuralgia, Postherpetic; Quality of Life | 2022 |
Intravenous Lidocaine in Chronic Neuropathic Pain: A Systematic Review.
Topics: Adult; Chronic Pain; Diabetic Neuropathies; Humans; Lidocaine; Neuralgia; Peripheral Nerve Injuries; | 2022 |
The Efficacy, Effectiveness and Safety of 5% Transdermal Lidocaine Patch for Chronic Low Back Pain: A Narrative Review.
Topics: Anesthetics, Local; Chronic Pain; Humans; Lidocaine; Low Back Pain; Randomized Controlled Trials as | 2020 |
Comprehensive Review of Topical Analgesics for Chronic Pain.
Topics: Administration, Topical; Analgesics; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; An | 2021 |
Lidocaine Infusions for Pain Management in Pediatrics.
Topics: Adolescent; Anesthesia, Local; Anesthetics, Local; Child; Chronic Pain; Female; Humans; Infusions, I | 2021 |
Safety and Efficacy of Intravenous Lidocaine for Pain Management in the Emergency Department: A Systematic Review.
Topics: Acute Pain; Administration, Intravenous; Anesthetics, Local; Chronic Pain; Emergency Service, Hospit | 2018 |
Intravenous lidocaine infusion.
Topics: Anesthesia; Anesthetics, Local; Chronic Pain; Humans; Infusions, Intravenous; Lidocaine; Neoplasm Re | 2018 |
Chronic postsurgical pain and cancer: the catch of surviving the unsurvivable.
Topics: Analgesics; Analgesics, Opioid; Cancer Pain; Chronic Pain; Drug Therapy, Combination; Gabapentin; Ge | 2018 |
Comparative Efficacy of Therapeutics for Chronic Cancer Pain: A Bayesian Network Meta-Analysis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bayes Theorem; Bridged Bicyclo Compou | 2019 |
Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review.
Topics: Acute Pain; Analgesics; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Chronic Pain; H | 2019 |
Topical therapies in the management of chronic pain.
Topics: Administration, Cutaneous; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; C | 2013 |
The in vitro mechanisms and in vivo efficacy of intravenous lidocaine on the neuroinflammatory response in acute and chronic pain.
Topics: Acute Pain; Administration, Intravenous; Anesthetics, Local; Animals; Calcium Channels; Chronic Pain | 2016 |
Effect of Perioperative Intravenous Lidocaine Infusion on Acute and Chronic Pain after Breast Surgery: A Meta-Analysis of Randomized Controlled Trials.
Topics: Acute Pain; Analgesics; Chronic Pain; Female; Humans; Infusions, Intravenous; Lidocaine; Mastectomy; | 2017 |
Persistent hiccups after interventional pain procedures: a case series and review.
Topics: Adult; Back Pain; Betamethasone; Chronic Pain; Dexamethasone; Hiccup; Humans; Injections, Spinal; Li | 2012 |
23 trials available for lidocaine and Pain, Chronic
Article | Year |
---|---|
Magnesium-Based Trigger Point Infiltrations Versus Local Anaesthetic Infiltrations in Chronic Pelvic Myofascial Pain: A Randomized, Double-Blind, Controlled Study.
Topics: Anesthetics, Local; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Magnesium; Myofasc | 2022 |
Effect of lidocaine perioperative infusion on chronic postsurgical pain in patients undergoing thoracoscopic radical pneumonectomy.
Topics: Analgesics, Opioid; Anesthetics, Local; Chronic Pain; Double-Blind Method; Humans; Lidocaine; Pain, | 2022 |
Evaluation of the Effect of New Multimodal Analgesia Regimen for Cardiac Surgery: A Prospective, Randomized Controlled, Single-Center Clinical Study.
Topics: Acetaminophen; Analgesia; Cardiac Surgical Procedures; Chronic Pain; Dexmedetomidine; Gabapentin; Hu | 2023 |
The short-term efficacy of electrical pudendal nerve stimulation versus intravesical instillation for the urethral pain syndrome: a randomized clinical trial.
Topics: Administration, Intravesical; Anesthetics, Local; Chronic Pain; Electric Stimulation Therapy; Female | 2021 |
The Effect of Intraoperative Systemic Lidocaine on Postoperative Persistent Pain Using Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials Criteria Assessment Following Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Cont
Topics: Administration, Intravenous; Adult; Analgesics, Opioid; Anesthetics, Local; Breast Neoplasms; Chroni | 2018 |
Acute effects of anesthetic lumbar spine injections on temporal spatial parameters of gait in individuals with chronic low back pain: A pilot study.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Epidural; Anesthetics, Local; Chronic Pain; Female; Fluo | 2017 |
Electromyographic characterisation of abdominal wall trigger points developed after caesarean section and response to local anaesthesia: an observational study.
Topics: Abdominal Wall; Adult; Anesthesia, Local; Anesthetics, Local; Brazil; Cesarean Section; Chronic Pain | 2018 |
Glucocorticoid injections for greater trochanteric pain syndrome: a randomised double-blind placebo-controlled (GLUTEAL) trial.
Topics: Adult; Aged; Anesthetics, Local; Betamethasone; Chronic Pain; Double-Blind Method; Female; Femur; Gl | 2019 |
Intravenous lidocaine in the management of chronic peripheral neuropathic pain: a randomized-controlled trial.
Topics: Aged; Anesthetics, Local; Chronic Pain; Cross-Over Studies; Diabetic Neuropathies; Diphenhydramine; | 2019 |
Effectiveness of Combination of Ultrasonography-Guided Pulsed Radiofrequency Neuromodulation With Steroid at the Suprascapular Nerve in Chronic Shoulder Pain.
Topics: Adult; Anesthetics, Local; Chronic Pain; Female; Humans; Injections, Intra-Articular; Lidocaine; Mal | 2020 |
A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia.
Topics: Aged; Aged, 80 and over; Capsaicin; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Ma | 2013 |
A comparison of cognitive-behavioral couple therapy and lidocaine in the treatment of provoked vestibulodynia: study protocol for a randomized clinical trial.
Topics: Administration, Intravaginal; Adolescent; Adult; Anesthetics, Local; Chronic Pain; Clinical Protocol | 2014 |
Efficacy and cost-effectiveness of intradiscal methylene blue injection for chronic discogenic low back pain: study protocol for a randomized controlled trial.
Topics: Analgesics; Anesthetics, Local; Chronic Pain; Clinical Protocols; Cost-Benefit Analysis; Disability | 2015 |
Anaesthetic injection versus ischemic compression for the pain relief of abdominal wall trigger points in women with chronic pelvic pain.
Topics: Abdominal Wall; Adult; Anesthetics, Local; Chronic Pain; Female; Humans; Lidocaine; Pain Threshold; | 2015 |
Paraspinous Lidocaine Injection for Chronic Nonspecific Low Back Pain: A Randomized Controlled Clinical Trial.
Topics: Adult; Analysis of Variance; Anesthetics, Local; Chronic Pain; Disability Evaluation; Exercise Thera | 2016 |
Photobiomodulation of the dorsal root ganglion for the treatment of low back pain: A pilot study.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Local; Chronic Pain; Female; Follow-Up Studies; Ganglia | 2016 |
The efficacy of intra-articular lidocaine administration in chronic knee pain due to osteoarthritis: A randomized, double-blind, controlled study.
Topics: Aged; Anesthetics, Local; Chronic Pain; Double-Blind Method; Female; Humans; Injections, Intra-Artic | 2017 |
The efficacy of intra-articular lidocaine administration in chronic knee pain due to osteoarthritis: A randomized, double-blind, controlled study.
Topics: Aged; Anesthetics, Local; Chronic Pain; Double-Blind Method; Female; Humans; Injections, Intra-Artic | 2017 |
The efficacy of intra-articular lidocaine administration in chronic knee pain due to osteoarthritis: A randomized, double-blind, controlled study.
Topics: Aged; Anesthetics, Local; Chronic Pain; Double-Blind Method; Female; Humans; Injections, Intra-Artic | 2017 |
The efficacy of intra-articular lidocaine administration in chronic knee pain due to osteoarthritis: A randomized, double-blind, controlled study.
Topics: Aged; Anesthetics, Local; Chronic Pain; Double-Blind Method; Female; Humans; Injections, Intra-Artic | 2017 |
The Effects of Intravenous Lidocaine Infusions on the Quality of Recovery and Chronic Pain After Robotic Thyroidectomy: A Randomized, Double-Blinded, Controlled Study.
Topics: Adult; Anesthetics, Local; Chronic Pain; Double-Blind Method; Female; Humans; Infusions, Intravenous | 2017 |
Effects of systemic lidocaine versus magnesium administration on postoperative functional recovery and chronic pain in patients undergoing breast cancer surgery: A prospective, randomized, double-blind, comparative clinical trial.
Topics: Adult; Breast Neoplasms; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Magnesium; Mi | 2017 |
Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study.
Topics: Back Pain; Brain; Brain Mapping; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Magne | 2012 |
Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study.
Topics: Back Pain; Brain; Brain Mapping; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Magne | 2012 |
Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study.
Topics: Back Pain; Brain; Brain Mapping; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Magne | 2012 |
Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study.
Topics: Back Pain; Brain; Brain Mapping; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Magne | 2012 |
Pulsed radiofrequency of suprascapular nerve for chronic shoulder pain: a randomized double-blind active placebo-controlled study.
Topics: Aged; Anesthetics, Local; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Male; Nerve | 2013 |
Management of chronic pain of cervical disc herniation and radiculitis with fluoroscopic cervical interlaminar epidural injections.
Topics: Adult; Anesthetics, Local; Betamethasone; Cervical Vertebrae; Chronic Pain; Double-Blind Method; Fem | 2012 |
The role of fluoroscopic interlaminar epidural injections in managing chronic pain of lumbar disc herniation or radiculitis: a randomized, double-blind trial.
Topics: Adult; Anesthetics, Local; Anti-Inflammatory Agents; Betamethasone; Chronic Pain; Double-Blind Metho | 2013 |
35 other studies available for lidocaine and Pain, Chronic
Article | Year |
---|---|
Nursing Care During Lidocaine Infusion Therapy for Chronic Pain.
Topics: Anesthetics, Local; Chronic Pain; Humans; Infusions, Intravenous; Lidocaine; Neuralgia; Pain Measure | 2022 |
Nerve injury induces transient locus coeruleus activation over time: role of the locus coeruleus-dorsal reticular nucleus pathway.
Topics: Animals; Chronic Pain; Hyperalgesia; Lidocaine; Locus Coeruleus; Male; Neuralgia; Rats; Rats, Spragu | 2022 |
Use of intravenous lignocaine in the perioperative and chronic pain setting.
Topics: Administration, Intravenous; Anesthetics, Local; Chronic Pain; Humans; Infusions, Intravenous; Lidoc | 2022 |
Effect of neuropathic pain on sphenopalatine ganglion block responses in persistent idiopathic facial pain.
Topics: Adult; Chronic Pain; Facial Pain; Humans; Lidocaine; Middle Aged; Neuralgia; Sphenopalatine Ganglion | 2023 |
Effect of neuropathic pain on sphenopalatine ganglion block responses in persistent idiopathic facial pain.
Topics: Adult; Chronic Pain; Facial Pain; Humans; Lidocaine; Middle Aged; Neuralgia; Sphenopalatine Ganglion | 2023 |
Effect of neuropathic pain on sphenopalatine ganglion block responses in persistent idiopathic facial pain.
Topics: Adult; Chronic Pain; Facial Pain; Humans; Lidocaine; Middle Aged; Neuralgia; Sphenopalatine Ganglion | 2023 |
Effect of neuropathic pain on sphenopalatine ganglion block responses in persistent idiopathic facial pain.
Topics: Adult; Chronic Pain; Facial Pain; Humans; Lidocaine; Middle Aged; Neuralgia; Sphenopalatine Ganglion | 2023 |
Effect of neuropathic pain on sphenopalatine ganglion block responses in persistent idiopathic facial pain.
Topics: Adult; Chronic Pain; Facial Pain; Humans; Lidocaine; Middle Aged; Neuralgia; Sphenopalatine Ganglion | 2023 |
Effect of neuropathic pain on sphenopalatine ganglion block responses in persistent idiopathic facial pain.
Topics: Adult; Chronic Pain; Facial Pain; Humans; Lidocaine; Middle Aged; Neuralgia; Sphenopalatine Ganglion | 2023 |
Effect of neuropathic pain on sphenopalatine ganglion block responses in persistent idiopathic facial pain.
Topics: Adult; Chronic Pain; Facial Pain; Humans; Lidocaine; Middle Aged; Neuralgia; Sphenopalatine Ganglion | 2023 |
Effect of neuropathic pain on sphenopalatine ganglion block responses in persistent idiopathic facial pain.
Topics: Adult; Chronic Pain; Facial Pain; Humans; Lidocaine; Middle Aged; Neuralgia; Sphenopalatine Ganglion | 2023 |
Effect of neuropathic pain on sphenopalatine ganglion block responses in persistent idiopathic facial pain.
Topics: Adult; Chronic Pain; Facial Pain; Humans; Lidocaine; Middle Aged; Neuralgia; Sphenopalatine Ganglion | 2023 |
Simultaneous application of lidocaine and ketamine during ambulatory infusion therapy: a retrospective analysis.
Topics: Chronic Pain; Humans; Infusions, Intravenous; Ketamine; Lidocaine; Retrospective Studies; Treatment | 2023 |
A novel, nonopiod-based treatment approach to men with urologic chronic pelvic pain syndrome using ultrasound-guided nerve hydrodissection and pelvic floor musculature trigger point injections.
Topics: Adult; Chronic Pain; Female; Humans; Lidocaine; Male; Middle Aged; Pain Measurement; Pelvic Floor; P | 2020 |
Assessment of Prevalence of Cervical Facet Joint Pain with Diagnostic Cervical Medial Branch Blocks: Analysis Based on Chronic Pain Model.
Topics: Adult; Anesthetics, Local; Arthralgia; Bupivacaine; Chronic Pain; Female; Humans; Lidocaine; Male; M | 2020 |
Chronic Localized Back Pain Due to Posterior Cutaneous Nerve Entrapment Syndrome (POCNES): A New Diagnosis.
Topics: Adult; Back Pain; Chronic Pain; Female; Humans; Intercostal Nerves; Lidocaine; Nerve Compression Syn | 2017 |
Tertiary Care Clinical Experience with Intravenous Lidocaine Infusions for the Treatment of Chronic Pain.
Topics: Adult; Aged; Anesthetics, Local; Chronic Pain; Female; Humans; Infusions, Intravenous; Lidocaine; Ma | 2018 |
Cardioprotection induced in a mouse model of neuropathic pain via anterior nucleus of paraventricular thalamus.
Topics: Animals; Butadienes; Chronic Pain; Disease Models, Animal; Enzyme Inhibitors; Ganglionic Blockers; H | 2017 |
Dopaminergic tone does not influence pain levels during placebo interventions in patients with chronic neuropathic pain.
Topics: Adult; Aged; Anesthetics, Local; Carbidopa; Chronic Pain; Dopamine; Dopamine Agents; Drug Combinatio | 2018 |
Nano-engineered microcapsules boost the treatment of persistent pain.
Topics: Anesthetics, Local; Animals; Animals, Newborn; Cells, Cultured; Chronic Pain; Drug Delivery Systems; | 2018 |
Diagnostic dilemma: think about anterior cutaneous nerve entrapment syndrome (ACNES) in patients with atypical abdominal pain and Crohn's disease.
Topics: Abdomen; Abdominal Pain; Amides; Anesthetics, Local; Chronic Pain; Crohn Disease; Diagnosis, Differe | 2018 |
Involvement of dopamine system in the regulation of the brain corticotropin-releasing hormone in paraventricular nucleus in a rat model of chronic visceral pain.
Topics: Animals; Animals, Newborn; Central Nervous System Agents; Chronic Pain; Corticotropin-Releasing Horm | 2018 |
Lidocaine infusions and preventative analgesia: can the answer to our prayers be hiding right under our noses?
Topics: Analgesia; Chronic Pain; Humans; Lidocaine; Pain Management | 2018 |
Corticotropin-Releasing Factor in the Brain and Blocking Spinal Descending Signals Induce Hyperalgesia in the Latent Sensitization Model of Chronic Pain.
Topics: Analgesics, Opioid; Animals; Brain; Central Nervous System Sensitization; Chronic Pain; Corticotropi | 2018 |
Loss-of-function of Nav1.8/D1639N linked to human pain can be rescued by lidocaine.
Topics: Action Potentials; Anesthetics, Local; Animals; Cell Line, Tumor; Cell Membrane; Chronic Pain; Human | 2018 |
Predictive value of a diagnostic block in focal nerve injury with neuropathic pain when surgery is considered.
Topics: Adolescent; Adult; Aged; Algorithms; Anesthetics, Local; Chronic Pain; Female; Humans; Lidocaine; Ma | 2018 |
An inadvertent subarachnoid injection reversed by cerebrospinal fluid lavage for the treatment of chronic low back pain: A case report.
Topics: Adrenal Cortex Hormones; Anesthesia, Epidural; Anesthesia, Spinal; Anesthetics, Local; Chronic Pain; | 2019 |
Efficacy of systemic lidocaine to reduce chronic postsurgical pain: case not yet closed….
Topics: Anesthetics, Local; Chronic Pain; Humans; Lidocaine | 2019 |
Reply.
Topics: Chronic Pain; Humans; Lidocaine | 2019 |
Pes Anserine Tendon Injury Resulting from Cooled Radiofrequency Ablation of the Inferior Medial Genicular Nerve.
Topics: Aged; Anesthetics, Local; Catheter Ablation; Chronic Pain; Combined Modality Therapy; Female; Follow | 2019 |
Fluoroscopically guided caudal epidural steroid injections for axial low back pain associated with central disc protrusions: a prospective outcome study.
Topics: Adult; Anesthetics, Local; Chronic Pain; Female; Fluoroscopy; Glucocorticoids; Humans; Injections, E | 2019 |
Clinical effectiveness of the obturator externus muscle injection in chronic pelvic pain patients.
Topics: Adult; Aged; Anesthetics, Local; Chronic Pain; Contrast Media; Female; Fluoroscopy; Humans; Injectio | 2015 |
Safety, tolerability, and short-term efficacy of intravenous lidocaine infusions for the treatment of chronic pain in adolescents and young adults: a preliminary report.
Topics: Adolescent; Anesthetics, Local; Back Pain; Chest Pain; Child; Chronic Pain; Female; Headache; Humans | 2014 |
Plasma concentrations and analgesic efficacy of lidocaine and prilocaine in leg ulcer-related pain during daily application of lidocaine-prilocaine cream (EMLA™) for 10 days.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Combined; Anesthetics, Local; Chronic Pain; Drug Admini | 2015 |
Prevalence of Anterior Cutaneous Nerve Entrapment Syndrome in a Pediatric Population With Chronic Abdominal Pain.
Topics: Abdominal Pain; Adolescent; Child; Chronic Pain; Cohort Studies; Cross-Sectional Studies; Female; Gl | 2016 |
Targeting Toll-like receptors to treat chronic pain.
Topics: Anesthetics, Local; Animals; Chronic Pain; Flagellin; Humans; Hyperalgesia; Lidocaine; Mice; Nerve F | 2015 |
Serratus Plane Block for Persistent Pain after Partial Mastectomy and Axillary Node Dissection.
Topics: Aged; Anesthetics, Local; Axilla; Chronic Pain; Female; Humans; Lidocaine; Lymph Node Excision; Mast | 2016 |
Efficacy of mesotherapy using drugs versus normal saline solution in chronic spinal pain: a retrospective study.
Topics: Analgesics; Anesthetics, Local; Aspirin; Back Pain; Chronic Pain; Female; Follow-Up Studies; Humans; | 2017 |
Time-dependent changes in bladder function and plantar sensitivity in a rat model of fibromyalgia syndrome induced by hydrochloric acid injection into the gluteus.
Topics: Anesthetics, Local; Animals; Case-Control Studies; Chronic Pain; Disease Models, Animal; Female; Fib | 2012 |
Patient perceptions associated with the 5% lidocaine medicated plaster in daily practice.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Anesthetics, Local; Bandages, Hydrocolloid; Chro | 2012 |
Treatment of acute and chronic focal neuropathic pain in cancer patients with lidocaine 5 % patches. A radiation and oncology department experience.
Topics: Acute Pain; Aged; Aged, 80 and over; Anesthetics, Local; Chronic Pain; Female; Humans; Lidocaine; Ma | 2013 |
Phenotyping the function of TRPV1-expressing sensory neurons by targeted axonal silencing.
Topics: Action Potentials; Anesthetics, Local; Animals; Axons; Behavior, Animal; Capsaicin; Chronic Pain; Di | 2013 |
LOCAL ANAESTHETICS FOR CHRONIC PAIN.
Topics: Anesthesia, Local; Anesthetics; Anesthetics, Local; Autonomic Nerve Block; Chronic Pain; Geriatrics; | 1964 |